These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2878583)

  • 1. Comparative studies on growth of foot-and-mouth disease virus types 0 and Asia 1 in BHK-21 Razi cells.
    Vasantha S; Antony A; Lal SM
    Acta Virol; 1986 Sep; 30(5):367-72. PubMed ID: 2878583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of foot and mouth disease virus and procapsid synthesis by zinc ions. Brief report.
    Firpo EJ; Palma EL
    Arch Virol; 1979; 61(1-2):175-81. PubMed ID: 229792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electron microscopy studies on the proliferation of foot-and-mouth disease virus in cell cultures. II. Changes in nucleic acid metabolism of the cell nucleus].
    Schulze P; Olechnowitz AF
    Arch Exp Veterinarmed; 1975 Jun; 29(3):427-39. PubMed ID: 172042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of insecticides on metabolism and susceptibility of IB-RS-2 cells to foot-and-mouth disease virus (author's transl)].
    Puga FR; La Regina Rodrigues MA
    Arq Inst Biol (Sao Paulo); 1974; 41(3):141-5. PubMed ID: 4374910
    [No Abstract]   [Full Text] [Related]  

  • 5. Dependence of RNA replication on continuous protein synthesis in a temperature-sensitive mutant of foot-and-mouth disease virus.
    Manor D; Barzilai R; Goldblum N
    J Gen Virol; 1974 Oct; 25(1):157-61. PubMed ID: 4372312
    [No Abstract]   [Full Text] [Related]  

  • 6. Stability of foot-and-mouth disease virus, its genome and proteins at 37 degrees C.
    Razdan R; Sen AK; Rao BV; Suryanarayana VV
    Acta Virol; 1996 Feb; 40(1):9-14. PubMed ID: 8886092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular distribution of the foot-and-mouth disease virus 3A protein in cells infected with viruses encoding wild-type and bovine-attenuated forms of 3A.
    O'Donnell VK; Pacheco JM; Henry TM; Mason PW
    Virology; 2001 Aug; 287(1):151-62. PubMed ID: 11504550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of actinomycin D and guanidine on the formation of a ribonucleic acid polymerase induced by foot-and mouth-disease virus and on the replication of virus and viral ribonucleic acid.
    Black DN; Brown F
    Biochem J; 1969 Apr; 112(3):317-23. PubMed ID: 4308295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of a hypertonic medium on cell susceptibility to foot-and-mouth disease virus].
    Koseki I
    Arq Inst Biol (Sao Paulo); 1978; 45(4):273-80. PubMed ID: 224844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The production of foot-and-mouth disease virus from BHK 21 C 13 cells grown on the surface of glass spheres.
    Spier RE; Whiteside JP
    Biotechnol Bioeng; 1976 May; 18(5):649-57. PubMed ID: 179634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-inhibition to heterologous foot-and-mouth disease virus infection induced by RNA interference targeting the conserved regions of viral genome.
    Liu M; Chen W; Ni Z; Yan W; Fei L; Jiao Y; Zhang J; Du Q; Wei X; Chen J; Liu Y; Zheng Z
    Virology; 2005 May; 336(1):51-9. PubMed ID: 15866070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of interferon and guanidine on the inactivation of RNA of foot-and-mouth disease virus infected cells].
    Ahl R
    Hoppe Seylers Z Physiol Chem; 1973; 354(10-11):1164-5. PubMed ID: 4373360
    [No Abstract]   [Full Text] [Related]  

  • 13. Mode of penetration and intracellular localization of incoming parental foot and mouth disease virus (FMDV) in BHK cells.
    Rossetti OL; Campos RH; Carrillo EC; de Torres RA
    Microbiologica; 1983 Jan; 6(1):35-44. PubMed ID: 6302446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of rifampicin, actinomycin D and mitomycin C on poliovirus and foot-and-mouth disease virus replication.
    Grado C; Ohlbaum A
    J Gen Virol; 1973 Nov; 21(2):297-303. PubMed ID: 4357749
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the infectivity of foot-and-mouth disease virus RNA using microinjection.
    Belsham GJ; Bostock CJ
    J Gen Virol; 1988 Feb; 69 ( Pt 2)():265-74. PubMed ID: 2448416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus.
    Rosas MF; Vieira YA; Postigo R; Martín-Acebes MA; Armas-Portela R; Martínez-Salas E; Sobrino F
    Virology; 2008 Oct; 380(1):34-45. PubMed ID: 18694581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial replacement of serum with peptone and lactalbumin hydrolysate for the production of foot-and-mouth disease vaccine in BHK-21 cells.
    Saha SN; Sen AK
    Acta Virol; 1989 Aug; 33(4):338-43. PubMed ID: 2574940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sedimentation characteristics of virion RNA of Machupo virus reproducing in the presence of actinomycin D].
    Golubev VP; Scheslenok EP; Finskaia NN; Lukashevich IS
    Mol Gen Mikrobiol Virusol; 1985 Jun; (6):37-40. PubMed ID: 3025713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction of a chimeric Theiler's murine encephalomyelitis virus containing the leader gene of foot-and-mouth disease virus.
    Piccone ME; Chen HH; Roos RP; Grubman MJ
    Virology; 1996 Dec; 226(1):135-9. PubMed ID: 8941332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimum number of cells required for reconstitution of a foot-and-mouth disease virus-carrier cell culture.
    de la Torre JC; Domingo E
    Microbiologia; 1988 Dec; 4(3):161-6. PubMed ID: 2855980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.